10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q3 2015

Filing Information

Form Type	10-Q
Accession Number	`0001144204-16-082296`
Period End Date	20151231
Filing Date	20160216
Fiscal Year	2015
Fiscal Period	Q3
XBRL Instance	ameh-20151231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 90 Cash Flow Statement 114

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.95M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.64M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$3.65M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$3.80M	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$514.82K	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$208.29K	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$20.05K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$36.40K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$278.92K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	5.46M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	5.46M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$350.08K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.86M	shares	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	$8.23K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.86M	shares	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	$513.65K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.19M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.85M	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$250.03K	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$264.71K	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.22M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$582.47K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$530.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$530.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.24M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.38M	USD	Point-in-time
Goodwill	`Goodwill`	$2.17M	USD	Point-in-time
Goodwill	`Goodwill`	$2.17M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$219.65K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$218.72K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$14.57M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.71M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.34M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.94M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.26M	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$88.76K	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$327.14K	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$7.39M	USD	Point-in-time
Convertible notes payable, net of discount, current portion	`ConvertibleNotesPayableCurrent`	$1.09M	USD	Point-in-time
Convertible notes payable, net of discount, current portion	`ConvertibleNotesPayableCurrent`	$1.04M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.97M	USD	Point-in-time
Notes payable, net of discount, non-current portion	`LongTermNotesPayable`	$6.23M	USD	Point-in-time
Notes payable, net of discount, non-current portion	`LongTermNotesPayable`	-	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$1.46M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.09M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.14M	USD	Point-in-time
Deferred rent liability	`DeferredRentCreditNoncurrent`	$11.61K	USD	Point-in-time
Deferred rent liability	`DeferredRentCreditNoncurrent`	$680.34K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$171.22K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$180.41K	USD	Point-in-time
Total liabilities	`Liabilities`	$15.99M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.78M	USD	Point-in-time
COMMITMENTS, CONTINGENCIES AND SUBSEQUENT EVENTS	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS, CONTINGENCIES AND SUBSEQUENT EVENTS	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 5,463,389 and 4,863,389 shares issued and outstanding as of December 31, 2015 and March 31, 2015, respectively	`CommonStockValue`	$5.46K	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 5,463,389 and 4,863,389 shares issued and outstanding as of December 31, 2015 and March 31, 2015, respectively	`CommonStockValue`	$4.86K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$19.42M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$16.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-24.04M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.34M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-4.62M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-2.82M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.83M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$2.32M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.29M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-990.18K	USD	Point-in-time
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$14.57M	USD	Point-in-time
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$15.00M	USD	Point-in-time

Income Statement 90 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$7.64M	USD	1 Quarter
Net revenues	`Revenues`	$10.66M	USD	1 Quarter
Net revenues	`Revenues`	$23.40M	USD	3 Qtrs
Net revenues	`Revenues`	$32.23M	USD	3 Qtrs
Cost of services	`CostOfServices`	$15.51M	USD	3 Qtrs
Cost of services	`CostOfServices`	$8.46M	USD	1 Quarter
Cost of services	`CostOfServices`	$24.30M	USD	3 Qtrs
Cost of services	`CostOfServices`	$6.09M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$11.19M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.51M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.35M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.89M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$194.06K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$145.59K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$287.03K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$399.24K	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$24.26M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$12.12M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$35.77M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$9.17M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.46M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.54M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-859.65K	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.53M	USD	1 Quarter
Interest expense	`InterestExpense`	$969.06K	USD	3 Qtrs
Interest expense	`InterestExpense`	$100.98K	USD	1 Quarter
Interest expense	`InterestExpense`	$362.94K	USD	1 Quarter
Interest expense	`InterestExpense`	$109.95K	USD	1 Quarter
Interest expense	`InterestExpense`	$530.20K	USD	3 Qtrs
Gain on change in fair value of warrant and conversion feature liabilities, net	`GainLossOnDerivativeInstrumentsNetPretax`	$382.13K	USD	1 Quarter
Gain on change in fair value of warrant and conversion feature liabilities, net	`GainLossOnDerivativeInstrumentsNetPretax`	$358.43K	USD	1 Quarter
Gain on change in fair value of warrant and conversion feature liabilities, net	`GainLossOnDerivativeInstrumentsNetPretax`	$480.57K	USD	3 Qtrs
Gain on change in fair value of warrant and conversion feature liabilities, net	`GainLossOnDerivativeInstrumentsNetPretax`	$313.53K	USD	3 Qtrs
Gain on change in fair value of warrant and conversion feature liabilities, net	`GainLossOnDerivativeInstrumentsNetPretax`	$430.40K	USD	1 Quarter
Loss on debt extinguishment	`ExtinguishmentOfDebtGainLossNetOfTax`	-	USD	1 Quarter
Loss on debt extinguishment	`ExtinguishmentOfDebtGainLossNetOfTax`	$-266.36K	USD	3 Qtrs
Loss on debt extinguishment	`ExtinguishmentOfDebtGainLossNetOfTax`	$-266.36K	USD	1 Quarter
Loss on debt extinguishment	`ExtinguishmentOfDebtGainLossNetOfTax`	-	USD	3 Qtrs
Other	`OtherNonoperatingIncomeExpense`	$112.65K	USD	1 Quarter
Other	`OtherNonoperatingIncomeExpense`	$-94.43K	USD	3 Qtrs
Other	`OtherNonoperatingIncomeExpense`	$-100.34K	USD	1 Quarter
Other	`OtherNonoperatingIncomeExpense`	$51.74K	USD	3 Qtrs
Total other (expense) income	`NonoperatingIncomeExpense`	$108.15K	USD	1 Quarter
Total other (expense) income	`NonoperatingIncomeExpense`	$-577.47K	USD	3 Qtrs
Total other (expense) income	`NonoperatingIncomeExpense`	$-436.76K	USD	3 Qtrs
Total other (expense) income	`NonoperatingIncomeExpense`	$-37.30K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.50M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.11M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.42M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.30M	USD	3 Qtrs
Income tax (benefit) provision	`IncomeTaxExpenseBenefit`	$-57.25K	USD	3 Qtrs
Income tax (benefit) provision	`IncomeTaxExpenseBenefit`	$36.20K	USD	1 Quarter
Income tax (benefit) provision	`IncomeTaxExpenseBenefit`	$66.65K	USD	3 Qtrs
Income tax (benefit) provision	`IncomeTaxExpenseBenefit`	$-31.94K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.36M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.53M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.06M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.39M	USD	1 Quarter
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$629.96K	USD	3 Qtrs
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$642.05K	USD	3 Qtrs
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$300.14K	USD	1 Quarter
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$152.65K	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.99M	USD	3 Qtrs
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.69M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-4.70M	USD	3 Qtrs
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.69M	USD	1 Quarter
Unrealized loss on change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Unrealized loss on change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	3 Qtrs
Unrealized loss on change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-33.09K	USD	1 Quarter
Unrealized loss on change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.69M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.99M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.70M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.72M	USD	1 Quarter
BASIC	`EarningsPerShareBasic`	$-0.31	USD	1 Quarter
BASIC	`EarningsPerShareBasic`	$-0.41	USD	3 Qtrs
BASIC	`EarningsPerShareBasic`	$-0.35	USD	1 Quarter
BASIC	`EarningsPerShareBasic`	$-0.93	USD	3 Qtrs
DILUTED	`EarningsPerShareDiluted`	$-0.35	USD	1 Quarter
DILUTED	`EarningsPerShareDiluted`	$-0.31	USD	1 Quarter
DILUTED	`EarningsPerShareDiluted`	$-0.41	USD	3 Qtrs
DILUTED	`EarningsPerShareDiluted`	$-0.93	USD	3 Qtrs
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	5.03M	shares	3 Qtrs
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	4.88M	shares	1 Quarter
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	4.90M	shares	3 Qtrs
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	5.37M	shares	1 Quarter
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	4.90M	shares	3 Qtrs
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	4.88M	shares	1 Quarter
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.37M	shares	1 Quarter
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.03M	shares	3 Qtrs

Cash Flow Statement 114 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-1.36M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.53M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.06M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.39M	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$196.00K	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$64.81K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$194.06K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$145.59K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$287.03K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$399.24K	USD	3 Qtrs
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	-	USD	3 Qtrs
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	$49.79K	USD	3 Qtrs
Deferred income tax	`DeferredIncomeTaxExpenseBenefit`	$9.19K	USD	3 Qtrs
Deferred income tax	`DeferredIncomeTaxExpenseBenefit`	$13.03K	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$179.29K	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$26.51K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$156.55K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$1.13M	USD	3 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-266.36K	USD	3 Qtrs
Amortization of financing costs	`AdjustmentForAmortization`	$77.79K	USD	3 Qtrs
Amortization of financing costs	`AdjustmentForAmortization`	$91.96K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$288.58K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$-42.04K	USD	3 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$382.13K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$358.43K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$480.57K	USD	3 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$313.53K	USD	3 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$430.40K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$49.12K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$850.82K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-96.25K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$12.43K	USD	3 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-80.30K	USD	3 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-16.34K	USD	3 Qtrs
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-2.74K	USD	3 Qtrs
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$71.16K	USD	3 Qtrs
Deferred financing costs	`IncreaseDecreaseInDeferredCharges`	-	USD	3 Qtrs
Deferred financing costs	`IncreaseDecreaseInDeferredCharges`	$-517.13K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$102.69K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$930.00	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$371.91K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$606.97K	USD	3 Qtrs
Deferred rent liability	`IncreaseDecreaseInOtherDeferredLiability`	-	USD	3 Qtrs
Deferred rent liability	`IncreaseDecreaseInOtherDeferredLiability`	$9.37K	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$831.84K	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$678.63K	USD	3 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$652.32K	USD	3 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.83M	USD	3 Qtrs
Acquisition, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.08M	USD	3 Qtrs
Acquisition, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Proceeds from sales of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	3 Qtrs
Proceeds from sales of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$438.88K	USD	3 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$37.21K	USD	3 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$165.98K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-2.67M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-165.98K	USD	3 Qtrs
Proceeds from issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$10.00M	USD	3 Qtrs
Proceeds from issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	3 Qtrs
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	$2.00M	USD	3 Qtrs
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$1.00M	USD	3 Qtrs
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	-	USD	3 Qtrs
Repayments on line of credit	`RepaymentsOfLinesOfCredit`	-	USD	3 Qtrs
Repayments on line of credit	`RepaymentsOfLinesOfCredit`	$1.00M	USD	3 Qtrs
Principal payments on term note payable	`PrincipalPaymentsOnTermNotePayable`	$813.58K	USD	3 Qtrs
Principal payments on term note payable	`PrincipalPaymentsOnTermNotePayable`	$6.53M	USD	3 Qtrs
Contribution by non-controlling interest	`ProceedsFromMinorityShareholders`	$586.11K	USD	3 Qtrs
Contribution by non-controlling interest	`ProceedsFromMinorityShareholders`	$400.00K	USD	1 Quarter
Contribution by non-controlling interest	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Distributions to non-controlling interest	`PaymentsToMinorityShareholders`	$595.42K	USD	3 Qtrs
Distributions to non-controlling interest	`PaymentsToMinorityShareholders`	$600.00K	USD	3 Qtrs
Repurchase of equity interests	`PaymentsForRepurchaseOfCommonStock`	$251.85K	USD	3 Qtrs
Repurchase of equity interests	`PaymentsForRepurchaseOfCommonStock`	$10.00K	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$20.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.14M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.63M	USD	3 Qtrs
NET CHANGE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-369.52K	USD	3 Qtrs
NET CHANGE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$120.28K	USD	3 Qtrs
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.95M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$4.64M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.95M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$4.64M	USD	Point-in-time
Interest paid	`InterestPaid`	$499.01K	USD	3 Qtrs
Interest paid	`InterestPaid`	$514.22K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$18.59K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$93.95K	USD	3 Qtrs
Holdback liability	`AcquisitionRelatedHoldbackLiabilityConsideration`	$376.24K	USD	3 Qtrs
Holdback liability	`AcquisitionRelatedHoldbackLiabilityConsideration`	-	USD	3 Qtrs
Issuance of convertible note warrant	`ConvertibleNoteWarrant`	$487.62K	USD	3 Qtrs
Issuance of convertible note warrant	`ConvertibleNoteWarrant`	-	USD	3 Qtrs
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	3 Qtrs
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$578.15K	USD	3 Qtrs
Warrant liability issued in connection with preferred stock	`NoncashOrPartnoncashValuationOfWarrantLiabilityIssued`	-	USD	3 Qtrs
Warrant liability issued in connection with preferred stock	`NoncashOrPartnoncashValuationOfWarrantLiabilityIssued`	$2.92M	USD	3 Qtrs
Issuance of common stock on conversion of warrants	`NoncashOrPartnoncashIssuanceOfCommonStockForExtinguishmentOfDebt`	-	USD	3 Qtrs
Issuance of common stock on conversion of warrants	`NoncashOrPartnoncashIssuanceOfCommonStockForExtinguishmentOfDebt`	$1.66M	USD	3 Qtrs
Issuance of common stock on conversion of convertible note	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	3 Qtrs
Issuance of common stock on conversion of convertible note	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.40M	USD	3 Qtrs
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$132.00K	USD	3 Qtrs
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	3 Qtrs
Acquisition related consideration fair value of membership interests issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$274.15K	USD	3 Qtrs
Acquisition related consideration fair value of membership interests issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	3 Qtrs
Acquisition related deferred tax liabilities	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$172.95K	USD	3 Qtrs
Acquisition related deferred tax liabilities	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	-	USD	3 Qtrs
Tenant improvement allowance	`TenantImprovementAllowance`	$659.36K	USD	3 Qtrs
Tenant improvement allowance	`TenantImprovementAllowance`	-	USD	3 Qtrs
Change in Non-controlling interest ownership	`IncreaseDecreaseInNoncontrollingInterestOwnership`	$338.03K	USD	3 Qtrs
Change in Non-controlling interest ownership	`IncreaseDecreaseInNoncontrollingInterestOwnership`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.